| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/25/2002 | WO2002032941A3 The function of a haptoglobin-haemoglobin receptor and the uses thereof |
| 07/25/2002 | WO2002032422A3 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 07/25/2002 | WO2002031484A3 Methods for characterizing molecular interactions using affinity capture tandem mass spectrometry |
| 07/25/2002 | WO2002030478A3 Detection of the presence of a microbe or related substance at a location |
| 07/25/2002 | WO2002030256A3 Diagnostic indicator of thymic function |
| 07/25/2002 | WO2002023192A3 Nuclear envelope assembly assay |
| 07/25/2002 | WO2002022075A3 Odors discrimination based on spectral signatures |
| 07/25/2002 | WO2002020830A3 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds |
| 07/25/2002 | WO2002018537A3 Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents |
| 07/25/2002 | WO2002014489A3 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof |
| 07/25/2002 | WO2002012461A3 Regulation of human membrane-type serine protease |
| 07/25/2002 | WO2002010196A3 Identification of a novel glutamine transporter |
| 07/25/2002 | WO2002008386A3 Materials and methods for the enhancement of effective root nodulation in legumes |
| 07/25/2002 | WO2002006306A3 SUBSTRATES AND ASSAYS FOR β-SECRETASE ACTIVITY |
| 07/25/2002 | WO2002004659A3 Relative rates of cytochrome p450 metabolism |
| 07/25/2002 | WO2002002147A3 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 07/25/2002 | WO2001094413A3 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 07/25/2002 | WO2001092891A3 Regulating lipid levels via the zmax1 or hbm gene |
| 07/25/2002 | WO2001088126A3 REGULATION OF HUMAN α1Α ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR |
| 07/25/2002 | WO2001077685A3 Diagnosis and treatment of gastrointestinal disease |
| 07/25/2002 | WO2001075145A3 Ubiquitin ligase assay |
| 07/25/2002 | WO2001060992A3 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 07/25/2002 | WO2001045690A3 Use of bvdu for inhibiting the growth of hyperproliferative cells |
| 07/25/2002 | WO2001040452B1 Biologically active material |
| 07/25/2002 | WO2001036964B1 Device for testing samples of small volumes (1 to 100 microlitres) |
| 07/25/2002 | WO2001034201A9 Methods for inhibiting neurofibromatosis type 1 (nf1) |
| 07/25/2002 | WO2001032928A3 Methods of determining individual hypersensitivity to an agent |
| 07/25/2002 | WO2001032186A3 Inhibitors of the inositol polyphosphate 5-phosphatase ship2 molecule |
| 07/25/2002 | WO2001009187A9 Human monoclonal antibodies to her2/neu |
| 07/25/2002 | WO2001009041A9 System for protection of building water supplies against chemical and biological warfare agents |
| 07/25/2002 | WO2001004613A9 Microfabricated injector and capillary array assembly for high-resolution and high throughput separations |
| 07/25/2002 | WO2001004157A9 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS |
| 07/25/2002 | WO2001002600A9 Detection of analytes using attenuated enzymes |
| 07/25/2002 | WO2001002567A9 16405 receptor, a g-protein coupled receptor |
| 07/25/2002 | WO2001002559A9 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 07/25/2002 | WO2001002452A9 Polymer brushes for immobilizing molecules to a surface or substrate, where the polymers have water-soluble or water-dispersible segments and probes bonded thereto |
| 07/25/2002 | WO2001001150A9 Diagnostic test for thrombotic or thromboembolic disease |
| 07/25/2002 | WO2001000879A9 Novel kinases and uses thereof |
| 07/25/2002 | WO2001000829A9 Human endogenous retrovirus in breast cancer |
| 07/25/2002 | WO2001000812A9 22012, a novel human carboxypeptidase |
| 07/25/2002 | WO2001000811A9 17867, a novel human aminopeptidase |
| 07/25/2002 | WO2000056901A9 Linear and circular expression elements |
| 07/25/2002 | US20020100082 Method for determining content of heterologous individual |
| 07/25/2002 | US20020100069 Treating heart defects; obtain tissue, incubate with modulator of transcription, evaluate tissue for defect |
| 07/25/2002 | US20020099511 Scanner and method for setting voltage value of photomultiplier |
| 07/25/2002 | US20020099506 Methods and apparatus for predicting ligand binding interactions |
| 07/25/2002 | US20020099191 EDG8 receptor, its preparation and use |
| 07/25/2002 | US20020099190 Nuclelotide sequences coding protein for use in the treatment and prevention of atherosclerosis, osteoporosis and nervous system disorders |
| 07/25/2002 | US20020099181 Anti-fibroblast growth factor-8 monoclonal antibody |
| 07/25/2002 | US20020099169 Modulation of preferential transcription factor; obtain sample containing transcription factor, incubate with modulator, monitor transcriptional activity |
| 07/25/2002 | US20020099096 Useful for oral testosterone replacement therapy, male contraception, maintaining sexual desire in women, treating prostate cancer and imaging prostate cancer |
| 07/25/2002 | US20020099036 Selective androgen receptor modulators and methods of use thereof |
| 07/25/2002 | US20020099028 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 07/25/2002 | US20020099014 Method for treatment of insulin resistance in obesity and diabetes |
| 07/25/2002 | US20020099012 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/25/2002 | US20020099002 Diagnostic and therapeutic methods utilizing antiangiogenic agents which bind Gb3 or CD77, e.g., verotoxins; treating multiple drug resistant tumors |
| 07/25/2002 | US20020098998 P27 prevents cellular migration |
| 07/25/2002 | US20020098598 Generating chemical libraries; obtain chemical intermediates, mix in vial, monitor reaction, monitor product generated |
| 07/25/2002 | US20020098597 Antibodies to lipoproteins and apolipoproteins and methods of use thereof |
| 07/25/2002 | US20020098595 Classification of prefrential proteins; obtain sample, insert into apparatus, analyze protein through mass spectroscopy |
| 07/25/2002 | US20020098591 Rapid assay for testing overall oxidative stress |
| 07/25/2002 | US20020098590 Diagnosing rhinitis, asthma and eczema in humans; obtain blood, measure concentration of eosinophil cationic protein in blood, amplified amount indicate allergic response |
| 07/25/2002 | US20020098589 Multi-purpose reagent system and method for enumeration of red blood cells, white blood cells and thrombocytes and differential determination of white blood cells |
| 07/25/2002 | US20020098581 Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor |
| 07/25/2002 | US20020098580 MDM interacting protein and methods of use thereof |
| 07/25/2002 | US20020098575 Alignment mechanism for two-electrode voltage-clamp perfusion chamber for electrophysiological testing of oocytes |
| 07/25/2002 | US20020098573 Generating preferential vector nucleotide sequences; obtain nucleotide sequences, incubate with preferential exogenous nucleotide sequences, ligate, recover nucleotide sequences |
| 07/25/2002 | US20020098546 Canine TAg1 proteins, nucleic acid molecules, and uses thereof |
| 07/25/2002 | US20020098544 Polypeptide for use in screening bactericides |
| 07/25/2002 | US20020098535 Class characterization of circulating cancer cells isolated from body fluids and methods of use |
| 07/25/2002 | US20020098533 PKC monocyte assay |
| 07/25/2002 | US20020098532 Testing gonadtrophin concentration in urine; obtain urine sample, incubate with antibody, determine gonadtrophin concentration |
| 07/25/2002 | US20020098531 Rapid methods for microbial typing and enumeration |
| 07/25/2002 | US20020098530 Tumor suppressor gene |
| 07/25/2002 | US20020098529 Detecting cells expressing preferential particles; obtain cells, mix with coated nanostructures, detect cells with bound nanostructures |
| 07/25/2002 | US20020098528 Methods and apparatus for blood typing with optical bio-disc |
| 07/25/2002 | US20020098527 Gene recombinant antibody and antibody fragment thereof |
| 07/25/2002 | US20020098526 Apparatus for use in the detection of preferential particles in sample |
| 07/25/2002 | US20020098524 Screening peptide library for preferential proteins; obtain library, incubate with antitarget, separate unbound peptides, incubate unbound peptides with target binding protein, detect bound peptide complexes |
| 07/25/2002 | US20020098520 Diagnosing preferential nervous system disorders; obtain protein sample, monitor g protein activity, adjustment in activity suggest nervous system disorder |
| 07/25/2002 | US20020098518 Rapid identification of conditions, compounds, or compositions that inhibit, prevent, induce, modify, or reverse transitions of physical state |
| 07/25/2002 | US20020098517 Monitoring amino acid sequence of preferential proteins; obtain protein, label, monitor signal from labeled protein |
| 07/25/2002 | US20020098516 Diagnosing preferential genetic disorder in humans; obtain sample, incubate with antibody, detect bound antibody, compare to control, evaluate pattern for genetic disorder |
| 07/25/2002 | US20020098513 Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof |
| 07/25/2002 | US20020098512 Apparatus for use in the analysis and detection of methamphetamines |
| 07/25/2002 | US20020098507 Nucleotide sequences coding polypeptide for use in human diagnostics and therapeutics; for use as biosensors |
| 07/25/2002 | US20020098506 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/25/2002 | US20020098505 Nucleotide sequences coding polypeptide for use in human diagnostics, therapeutics; for use as biosensors |
| 07/25/2002 | US20020098498 Daniagosing and detectcting genetic disorders; obtain humans, monitor phenotype, obtain tissue sample, screen tissue with preferential probes, detect signal, presence of signal indicates polymorphism |
| 07/25/2002 | US20020098497 Detecting preferential receptors in sample; obtain sample, incubate with binding protein, detect bound receptor |
| 07/25/2002 | US20020098490 Method for assaying DNA fragments in mixture |
| 07/25/2002 | US20020098477 Methods for screening nuclear transcription factors for the ability to modulate an estrogen response |
| 07/25/2002 | US20020098476 Classification and evaluation of viral infection; obtain cells, monitor expresson of preferential glycoprotein, monitor lymphocytes in sample, evaluate infection |
| 07/25/2002 | US20020098202 Efficient hepatitis C virus replicon and its use in identifying antiviral compounds |
| 07/25/2002 | US20020098201 Novel myxoma genes for immune modulation |
| 07/25/2002 | US20020098192 Polyalkylene oxide-modified single chain polypeptides |
| 07/25/2002 | US20020098189 Have specificity for antigens displayed by microorganisms, especially viruses, as well as antigenic sites present on cancer cells and on various types of toxins, and products of toxins |
| 07/25/2002 | US20020098177 17867, a novel human aminopeptidase |
| 07/25/2002 | US20020098169 Novel sequences and their use |
| 07/25/2002 | US20020098120 Oxygen monitoring apparatus and methods of using the apparatus |